Obstacles and opportunities in Chinese pharmaceutical innovation

Globalization and Health
[Accessed 25 March 2017]

Obstacles and opportunities in Chinese pharmaceutical innovation
Global healthcare innovation networks nowadays have expanded beyond developed countries with many developing countries joining the force and becoming important players. China, in particular, has seen a significant increase in the number of innovative firms and research organizations stepping up to the global network in recent years. Nevertheless, the intense Research and Development input has not brought about the expectable output. While China is ascending at a great speed to a leading position worldwide in terms of Research and Development investment, scientific publications and patents, the innovation capabilities in the pharmaceutical sector remain weak.
Jingyun Ni, Junrui Zhao, Carolina Oi Lam Ung, Yuanjia Hu, Hao Hu and Yitao Wang
Globalization and Health 2017 13:21
Published on: 24 March 2017